[go: up one dir, main page]

DK1140119T3 - Anvendelse af heparin med lav molekylvægt til forebyggelse og/eller behandling af motorneuronale sygdomme - Google Patents

Anvendelse af heparin med lav molekylvægt til forebyggelse og/eller behandling af motorneuronale sygdomme

Info

Publication number
DK1140119T3
DK1140119T3 DK99958308T DK99958308T DK1140119T3 DK 1140119 T3 DK1140119 T3 DK 1140119T3 DK 99958308 T DK99958308 T DK 99958308T DK 99958308 T DK99958308 T DK 99958308T DK 1140119 T3 DK1140119 T3 DK 1140119T3
Authority
DK
Denmark
Prior art keywords
molecular weight
low molecular
prevention
treatment
weight heparin
Prior art date
Application number
DK99958308T
Other languages
English (en)
Inventor
Jean-Marie Stutzmann
Andre Uzan
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1140119T3 publication Critical patent/DK1140119T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • External Artificial Organs (AREA)
DK99958308T 1998-12-17 1999-12-13 Anvendelse af heparin med lav molekylvægt til forebyggelse og/eller behandling af motorneuronale sygdomme DK1140119T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9815919A FR2787329B1 (fr) 1998-12-17 1998-12-17 Nouvelle application therapeutique des heparines de bas poids moleculaire
EP99958308A EP1140119B1 (fr) 1998-12-17 1999-12-13 Utilisation des heparINES DE BAS POIDS MOLECULAIRE pour la prevention et/ou le traitement des maladies motoneuronales

Publications (1)

Publication Number Publication Date
DK1140119T3 true DK1140119T3 (da) 2004-12-20

Family

ID=9534065

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99958308T DK1140119T3 (da) 1998-12-17 1999-12-13 Anvendelse af heparin med lav molekylvægt til forebyggelse og/eller behandling af motorneuronale sygdomme

Country Status (15)

Country Link
US (4) US20020040013A1 (da)
EP (1) EP1140119B1 (da)
JP (1) JP2002532431A (da)
AT (1) ATE273711T1 (da)
AU (1) AU1569700A (da)
CA (1) CA2354762C (da)
DE (1) DE69919578T2 (da)
DK (1) DK1140119T3 (da)
ES (1) ES2222748T3 (da)
FR (1) FR2787329B1 (da)
IL (2) IL143279A0 (da)
NO (1) NO20012849D0 (da)
PT (1) PT1140119E (da)
SI (1) SI1140119T1 (da)
WO (1) WO2000035462A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
US7511026B2 (en) 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
EA008938B1 (ru) * 2003-03-28 2007-10-26 Апплайд Резеч Системз Арс Холдинг Н. В. Применение кластерина для лечения и/или профилактики периферических неврологических заболеваний
FR3000746A1 (fr) 2013-01-04 2014-07-11 Centre Nat Rech Scient Peptide pour son utilisation dans le traitement des neuronopathies motrices
RU2639574C2 (ru) * 2016-05-23 2017-12-21 Алексей Георгиевич Александров Способ получения низкомолекулярного гепарина

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions
JPH04507234A (ja) * 1988-04-22 1992-12-17 ベイラー・カレッジ・オブ・メディスン 筋萎縮性側索硬化症の治療用組成物の製造方法
CA2071898A1 (en) * 1989-10-27 1991-04-28 Diane M. Snow Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans
US6258341B1 (en) * 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
US6491965B1 (en) * 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
FR2763849B1 (fr) * 1997-05-28 2000-09-15 Rhone Poulenc Rorer Sa Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement des oedemes cerebraux
US6608042B2 (en) * 2000-03-28 2003-08-19 Aventis Pharma, S.A. Pharmaceutical compositions containing oligosaccharides, the novel oligosaccharides and preparation thereof

Also Published As

Publication number Publication date
US20040038938A1 (en) 2004-02-26
US20030236222A1 (en) 2003-12-25
US20020040013A1 (en) 2002-04-04
DE69919578T2 (de) 2005-07-14
ES2222748T3 (es) 2005-02-01
ATE273711T1 (de) 2004-09-15
WO2000035462A1 (fr) 2000-06-22
IL143279A0 (en) 2002-04-21
SI1140119T1 (en) 2004-10-31
JP2002532431A (ja) 2002-10-02
AU1569700A (en) 2000-07-03
DE69919578D1 (de) 2004-09-23
NO20012849L (no) 2001-06-08
NO20012849D0 (no) 2001-06-08
EP1140119A1 (fr) 2001-10-10
FR2787329B1 (fr) 2001-02-09
IL143279A (en) 2006-12-10
FR2787329A1 (fr) 2000-06-23
PT1140119E (pt) 2004-11-30
CA2354762A1 (fr) 2000-06-22
EP1140119B1 (fr) 2004-08-18
CA2354762C (fr) 2010-02-09
US20060100175A1 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
DE60035870D1 (de) Kombinationstherapie zur gewichtsreduzierung und fettleibigkeitsbehandlung
DE69733329D1 (de) Verwendung von Taurin zur Behandlung oder Vorbeugung von ischämischen Verletzungen
NO992641D0 (no) Blandinger og fremgangsmÕter for behandling eller forhindring av betennelsessykdommer
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
DE60026627D1 (de) Reboxetin zur Behandlung von Fibromyalgie und anderen somatoformen Störungen
NO992769D0 (no) FremgangsmÕte for behandling og forhindring av hjertesvikt og ventricular dilasjon
DE69823459D1 (de) Herzbehandlungssystem zur Feststellung und Behandlung von Herzversagen
HUP0303917A2 (hu) Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére
NO20005884L (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
NO20011693D0 (no) Kombinasjon av karnitiner og resveratrol for forebygging eller behandling av cerebrale og aldringsforstyrrelser
DK0786991T3 (da) Polyaminforbindelsre til behandling af proliferative karsygdomme
ES2060918T3 (es) Derivados de ciclopropilo que poseen actividad inhibidora lipoxigenasa.
BRPI0408491A (pt) tratamento da doença de alzheimer
NO20054913D0 (no) Anvendelse av clustein for behandling og/eller forebyggelse av perifere nevrologiske lidelser
DK1140119T3 (da) Anvendelse af heparin med lav molekylvægt til forebyggelse og/eller behandling af motorneuronale sygdomme
DK0888330T3 (da) Fremgangsmåder til behandling eller forebyggelse af interstitiel cystitis
DE69814993D1 (de) Quasi-azeotrope Mischungen auf Basis von 1,1,1,3,3,-Pentafluorobutan, Methylene Chloride und Methanol zur Behandlung von festen Oberflächen
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
DK0984787T3 (da) Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer
NO995538D0 (no) Anvendelse av hepariner med lav molekylvekt for prevensjon og terapi av sentralnervesystem-trauma
DK1133297T3 (da) Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin
ATE269714T1 (de) Tcf-ii für vorbeugung und/oder behandlung von strahlungsinduzierter störungen
KR940018945U (ko) 치질치료 및 예방용 좌욕조